On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer

Transl Lung Cancer Res. 2020 Oct;9(5):1712-1719. doi: 10.21037/tlcr-20-536.
No abstract available

Publication types

  • Editorial
  • Comment